Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Nausea and vomiting in advanced illness

Palliative and end-of-life care · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Vomiting with acute instability

Haematemesis, faeculent vomit, peritonism, severe distension, shock, aspiration, neurological deficit or reduced consciousness may indicate bleeding, obstruction, perforation, sepsis or raised intracranial pressure.

Action: Use ABCDE care, protect the airway, stop unsafe oral intake and medicines, obtain intravenous or subcutaneous access and call urgent medical or surgical help within the agreed ceiling. Treat hypoglycaemia and fluid or electrolyte compromise while providing antiemetic relief that does not delay imaging or definitive treatment.

Synopsis

Identify the dominant nausea mechanism and reversible emergencies, restore a reliable medicine route, choose one mechanism-matched antiemetic with explicit safety checks, and review symptom relief, hydration, nutrition and adverse effects against the person's goals.

  • First-line history defines nausea versus retching or vomiting, volume and content, relation to food, movement, medicines, bowels, headache and abdominal pain.
  • Examine hydration, mouth, abdomen, bowel sounds, rectum when indicated, neurology, vestibular signs and current patches, pumps and medicines.
  • Treat the cause when useful: constipation, obstruction, infection, hypercalcaemia, uraemia, gastric stasis, raised intracranial pressure and medicine toxicity need different interventions.
  • Choose the first antiemetic by dominant mechanism rather than prescribing several empirically: prokinetic, dopamine antagonist, antihistamine-antimuscarinic or serotonin antagonist each has a different role.
  • Metoclopramide is first-line for gastric stasis or partial obstruction without colic, but avoid it in complete mechanical obstruction, perforation, Parkinson's disease and previous dystonia.
  • Haloperidol can help chemically mediated nausea from opioids or organ failure; use low doses and review Parkinson, Lewy-body, QT and extrapyramidal risk.
  • Cyclizine can help vestibular or raised-pressure nausea and complete obstruction but adds anticholinergic effects and can oppose a prokinetic when combined without rationale.
  • Switch to subcutaneous, buccal, rectal or transdermal routes when vomiting makes oral absorption unreliable and reconcile essential medicines at the same time.
  • The gold-standard plan states the presumed mechanism, first medicine, rescue, route, response time, adverse-effect checks and a second-line strategy if the formulation is wrong.

Key red flags

Colicky pain, distension, constipation or obstipation and faeculent vomiting suggests mechanical bowel obstruction and makes routine prokinetic treatment unsafe in complete obstruction.

Rigid abdomen, rebound, fever, lactate rise or haemodynamic instability suggests perforation, ischaemia or peritonitis and requires urgent surgical assessment.

Haematemesis, coffee-ground material, melaena, syncope or anticoagulant exposure requires acute gastrointestinal-bleeding management.

Progressive morning headache, projectile vomiting, focal neurology, seizure or altered consciousness suggests raised intracranial pressure.

Polyuria, dehydration, constipation, confusion or arrhythmia may indicate hypercalcaemia and needs urgent calcium and renal assessment.

Repeated vomiting with poor urine output, postural hypotension or marked electrolyte disturbance threatens renal injury, delirium and arrhythmia.

New dystonia, akathisia, rigidity, QT symptoms or profound sedation after antiemetic therapy requires immediate medicine review.

Aspiration risk

Drowsiness, bulbar dysfunction, cough failure or active large-volume vomiting threatens airway contamination and requires immediate positioning and support.

Investigation priorities

01
First-line mechanism historyFirst stepFirst line

Link symptoms with meals, bowel function, movement, medicines, headache, pain, treatment and vomiting content and timing.

Management branches

Initial nauseaFormulate mechanism and secure the route

Nausea or vomiting is new, changed or inadequately controlled.

  1. Identify emergency features, assess hydration and aspiration, examine abdomen and neurology and reconcile bowel pattern, medicines and essential oral treatment.
  2. Treat reversible contributors and choose one antiemetic whose receptor and motility action fits the dominant mechanism and organ-function risks.
  3. Use a reliable route, prescribe rescue and review within the drug's onset window, documenting response, toxicity and the next branch if symptoms persist.

Key medicines

Metoclopramide for gastric stasisGive 10 mg orally or subcutaneously up to three times daily for a reviewed trial, reducing dose and extending interval in renal impairment according to the BNF and local palliative protocol.Avoid in complete mechanical obstruction, perforation, Parkinson's disease or previous dystonia; monitor akathisia, extrapyramidal effects, diarrhoea and opposing antimuscarinic treatment.
Haloperidol for chemical nauseaStart 500 micrograms to 1.5 mg orally or subcutaneously once daily or as a protocol-defined dose in a frail palliative adult, using the lowest effective total and reducing with hepatic impairment.Avoid routine use in Parkinson's disease or Lewy-body dementia; review QT, electrolytes, akathisia, rigidity, swallowing and interacting antipsychotics.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG31 care of dying adultsIndividual nausea assessment, reversible causes, route and antiemetic selection in the last days.
  • Scottish palliative nausea guidelineMechanism-led antiemetic selection, subcutaneous doses and safety cautions.
  • BNF antiemetics summaryUK antiemetic dosing, contraindications, interactions and adverse effects.
  • Scottish bowel obstruction guidelineProkinetic contraindications and medical management of malignant obstruction.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom